Usana Health Sciences INC DEF 14A proxy statements

USANA Health Sciences announces its 2026 Annual Meeting of Shareholders, to be held virtually on May 20, 2026, with key proposals including director elections and executive compensation.

USANA Health Sciences is asking shareholders to approve the USANA Health Sciences, Inc. 2025 Equity Incentive Plan to continue providing equity awards to directors, executive officers, employees, and consultants.

USANA Health Sciences is soliciting proxies for its upcoming Annual Meeting of Shareholders, featuring proposals including the election of directors, approval of the 2025 Equity Incentive Plan, and ratification of KPMG as the independent auditor.

USANA Health Sciences will hold its annual shareholder meeting virtually on May 19, 2025, to vote on key proposals including the election of directors, approval of the 2025 Equity Incentive Plan, ratification of KPMG LLP as the independent auditor, and executive compensation.

USANA Health Sciences announces its 2025 Annual Meeting of Shareholders to be held virtually on May 19, 2025, with key proposals including director elections, approval of a new equity incentive plan, and ratification of the independent auditor.

USANA Health Sciences, Inc. has filed a definitive proxy statement with the SEC regarding its upcoming shareholder meeting.

USANA Health Sciences will hold its annual shareholder meeting virtually on May 6, 2024, to vote on director elections, auditor ratification, and executive compensation.